AVISE MTX

Methotrexate Polyglutamates Test

AVISE MTX

Methotrexate
Polyglutamates Test


AVISE MTX provides accurate measurement of the active methotrexate (MTX) metabolites, methotrexate polyglutamates (MTXPGs), to help physicians appropriately assess their patients' exposure to methotrexate.

AVISE MTX helps assess variability in methotrexate pharmacokinetics.

Image

Clinical Utility

AVISE MTX Test Report


The AVISE MTX test is intended for use in patients on methotrexate treatment, after steady state (approx. 90 days), to help with therapeutic decision making including: 


  • Drug delivery route, i.e. oral vs. subcutaneous MTX therapy
  • Treatment changes

Image

2. Dervieux T, et al. Ann Rheum Dis 2005.